# Polysaccharides of Astragalus membranaceus

## PG2 inj 500mg

| TAH Drug Code      | [**IPG2**](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=IPG2)                                                                                                                                                                                                              |
|:-------------------|:--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | As a complementary and palliative medicine for managing cancer-related fatigue.                                                                                                                                                                                                       |
| Dosing             | Adults: 500 mg infused intravenously for 2.5-3.5 hours 2-4 times/week for a total of 2-4 weeks. Reconstitute each vial of 500 mg of PG2 with 10 mL normal saline. Shake thoroughly until dissolved completely. Mix the dissolved solution with normal saline (490mL) for IV infusion. |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                         |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                         |
| Contraindications  | 1.Hypersensitivity to Astragalus. 2.Precautionary use in individuals with autoimmune disease 3.Discontinue prior to elective surgery to reduce risk of bleeding                                                                                                                       |
| Adverse Effects    | Itching (2.38%), skin rash (9.21%), dizziness (2.38%), Fever(7.24%), feeling cold(5.26%), chills(2.63%)                                                                                                                                                                               |
| Pregnancy          | Unknown                                                                                                                                                                                                                                                                               |
| Lactation          | Unknown                                                                                                                                                                                                                                                                               |

